{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:49:50Z","timestamp":1791344990669,"version":"4.3.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170453"],"award-info":[{"award-number":["82170453"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004763","name":"Natural Science Foundation of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["2023MS08054"],"award-info":[{"award-number":["2023MS08054"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0533200"],"award-info":[{"award-number":["2024ZD0533200"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0533201"],"award-info":[{"award-number":["2024ZD0533201"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Hygiene and Environmental Health"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijheh.2026.114913","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:19:42Z","timestamp":1790468382000},"page":"114913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum legacy and emerging PFAS and lipid biomarkers in patients with chronic coronary syndrome: a cross-sectional human biomonitoring study"],"prefix":"10.1016","volume":"278","author":[{"given":"Chenyang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1239-9278","authenticated-orcid":false,"given":"Wenxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2956-4056","authenticated-orcid":false,"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijheh.2026.114913_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152845","article-title":"Why is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (PFAS) in humans? A workshop report on potential mechanisms","volume":"459","author":"Andersen","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.ijheh.2026.114913_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.176227","article-title":"Decreases in serum PFAS are associated with decreases in serum lipids: a longitudinal study on a highly exposed population","volume":"954","author":"Batzella","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ijheh.2026.114913_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ieam.258","article-title":"Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins","volume":"7","author":"Buck","year":"2011","journal-title":"Integrated Environ. Assess. Manag."},{"key":"10.1016\/j.ijheh.2026.114913_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106596","article-title":"Associations of perfluorooctane sulfonate alternatives and serum lipids in Chinese adults","volume":"155","author":"Cong","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.ijheh.2026.114913_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.112903","article-title":"Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - a longitudinal study over 10 years","volume":"211","author":"Dunder","year":"2022","journal-title":"Environ. Res."},{"key":"10.1016\/j.ijheh.2026.114913_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/biom13010105","article-title":"HDL functions-current status and future perspectives","volume":"13","author":"Endo","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijheh.2026.114913_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg9065","article-title":"Per- and polyfluoroalkyl substances in the environment","volume":"375","author":"Evich","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ijheh.2026.114913_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/etc.4890","article-title":"Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research","volume":"40","author":"Fenton","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.ijheh.2026.114913_bib9","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijheh.2026.114913_bib10","article-title":"Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study","volume":"36","author":"Hansen","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.ijheh.2026.114913_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.158036","article-title":"Perfluoroalkyl substances and lipid concentrations in the blood: a systematic review of epidemiological studies","volume":"850","author":"Ho","year":"2022","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ijheh.2026.114913_bib12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10654-025-01271-4","article-title":"The relationship between PFAS exposure and dyslipidemia: an updated review, meta-analysis, and evaluation of bias","volume":"40","author":"Hussey","year":"2025","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.ijheh.2026.114913_bib13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New Creatinine- and cystatin C\u2013Based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijheh.2026.114913_bib14","doi-asserted-by":"crossref","DOI":"10.1289\/EHP12351","article-title":"Per- and Polyfluoroalkyl Substances (PFAS) and lipid trajectories in women 45-56 years of Age: the Study of women\u2019s health across the nation","volume":"131","author":"Kang","year":"2023","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ijheh.2026.114913_bib15","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijheh.2026.114913_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.114361","article-title":"Integration of metabolomics and proteomics reveals the underlying hepatotoxic mechanism of perfluorooctane sulfonate (PFOS) and 6:2 chlorinated polyfluoroalkyl ether sulfonic acid (6:2 Cl-PFESA) in primary human hepatocytes","volume":"249","author":"Li","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ijheh.2026.114913_bib17","doi-asserted-by":"crossref","DOI":"10.1289\/EHP11840","article-title":"Associations between Per- and Polyfluoroalkyl Substances exposures and blood lipid levels among Adults-A meta-analysis","volume":"131","author":"Liu","year":"2023","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ijheh.2026.114913_bib18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamacardio.2022.0912","article-title":"Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations","volume":"7","author":"Liu","year":"2022","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijheh.2026.114913_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1289\/ehp.0901165","article-title":"Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population","volume":"118","author":"Nelson","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ijheh.2026.114913_bib20","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ijheh.2026.114913_bib21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/JOM.0b013e31825461d2","article-title":"Longitudinal assessment of lipid and hepatic clinical parameters in workers involved with the demolition of perfluoroalkyl manufacturing facilities","volume":"54","author":"Olsen","year":"2012","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.ijheh.2026.114913_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.117329","article-title":"6:2 Cl-PFESA has the potential to cause liver damage and induce lipid metabolism disorders in female mice through the action of PPAR-\u03b3","volume":"287","author":"Pan","year":"2021","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.ijheh.2026.114913_bib23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41370-025-00773-3","article-title":"Longitudinal association of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) exposure with lipid traits, in a healthy unselected population","volume":"35","author":"Raza","year":"2025","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.ijheh.2026.114913_bib24","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/JOM.0b013e318156eca3","article-title":"Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers","volume":"49","author":"Sakr","year":"2007","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.ijheh.2026.114913_bib25","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/aje\/kwp279","article-title":"Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant","volume":"170","author":"Steenland","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ijheh.2026.114913_bib26","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur. Heart J."}],"container-title":["International Journal of Hygiene and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438463926001732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438463926001732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:52:09Z","timestamp":1791341529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438463926001732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"alternative-id":["S1438463926001732"],"URL":"https:\/\/doi.org\/10.1016\/j.ijheh.2026.114913","relation":{},"ISSN":["1438-4639"],"issn-type":[{"value":"1438-4639","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum legacy and emerging PFAS and lipid biomarkers in patients with chronic coronary syndrome: a cross-sectional human biomonitoring study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Hygiene and Environmental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijheh.2026.114913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"114913"}}